R&D tax credit
Congress fails to renew for 2008 the now-expired federal research and development tax credit. Ratified in 1981 to encourage domestic innovation, the program has required renewal on average every one to two years and has been allowed to expire more than once. The Pharmaceutical Research and Manufacturers of America has joined a broad industry coalition that will be pushing next year for a retroactive renewal of the program that extends for multiple years and increases the size of the credit that some companies will qualify for, with the ultimate goal of making it permanent...
You may also be interested in...
Grant from Department of Commerce Market Development Cooperator Program funds project for four years. In addition to grant, the project partners – UNPA, National Animal Supplement Council, Eurofins Scientific testing company and China Inspections and Testing Society – get DoC assistance.
Avadim Health argues National Advertising Division expects substantiation for its homeopathic topical claims at the same level FDA requires for NDAs. NAD also said although FTC’s competent, reliable scientific evidence standard is “flexible” to some degree, pain claims are held to a more rigid standard.
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.